CompletedNCT05375890

Clinical and Neurophysiological Characteristics of Narcolepsy

Studying Narcolepsy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: I.M. Sechenov First Moscow State Medical University
Principal Investigator: Alexander Kuts
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Intervention: no intervention(other)
Enrollment: 89 enrolled
Eligibility: 7-78 years · All sexes
Timeline: 2019 – 2023

Study locations (11)

Regional Clinical Hospital No.3, Chelyabinsk, Russia
Kazan State Medical University, Kazan', Russia
Private healthcare institution 'Clinical hospital 'RZD-Medicine', Khabarovsk, Russia
Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia
FSBI NMRCO FMBA Russia, Moscow, Russia
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
Novosibirsk State Medical University, Novosibirsk, Russia
Almazov National Medical Research Centre, Saint Petersburg, Russia
Nikiforov Russian Center of Emergency and Radiation Medicine, EMERCOM of Russia, Saint Petersburg, Russia
V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint Petersburg, Russia
Samara State Medical University, Samara, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05375890 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy →

← Back to all trials